IFN-β sensitizes glioma cells to temozolomide in a MGMT- and p53-independent manner

被引：0
|
作者：
Happold, C. [1 ]
Roth, P. [1 ]
Adams, B. [2 ]
Weller, M. [1 ]
机构：
[1] Univ Spital Zurich, Neurol Klin, Zurich, Switzerland
[2] Univ Klin Tubingen, Tubingen, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [1] INF-β SENSITIZES GLIOMA CELLS TO TEMOZOLOMIDE IN AN MGMT- AND P53-INDEPENDENT MANNER
    Happold, C.
    Roth, P.
    Adams, B.
    Frei, K.
    Tabatabai, G.
    Bertalanffy, H.
    Weller, M.
    NEURO-ONCOLOGY, 2010, 12 : 15 - 16
  • [2] A combination of IFN-β and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation
    Atsushi Natsume
    Toshihiko Wakabayashi
    Dai Ishii
    Hideharu Maruta
    Masazumi Fujii
    Shinji Shimato
    Motokazu Ito
    Jun Yoshida
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 653 - 659
  • [3] A combination of IFN-β and temozolomide in human glioma xenograft models:: implication of p53-mediated MGMT downregulation
    Natsume, Atsushi
    Wakabayashi, Toshihiko
    Ishii, Dai
    Maruta, Hideharu
    Fujii, Masazumi
    Shimato, Shinji
    Ito, Motokazu
    Yoshida, Jun
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (04) : 653 - 659
  • [4] p14ARF sensitizes human osteosarcoma cells to cisplatin-induced apoptosis in a p53-independent manner
    Yuan, Xiang-Wei
    Zhu, Xiao-Feng
    Huang, Xiu-Fang
    Sheng, Pu-Yi
    He, Ai-Shan
    Yang, Zi-Bo
    Deng, Rong
    Feng, Gong-Kan
    Liao, Wei-Ming
    CANCER BIOLOGY & THERAPY, 2007, 6 (07) : 1074 - 1080
  • [5] Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma
    Ni, Xiang-Rong
    Guo, Cheng-Cheng
    Yu, Yan-Jiao
    Yu, Zhi-Hui
    Cai, Hai-Ping
    Wu, Wei-Chi
    Ma, Jun-Xiao
    Chen, Fu-Rong
    Wang, Jing
    Chen, Zhong-Ping
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (06) : 773 - 782
  • [6] Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma
    Xiang-Rong Ni
    Cheng-Cheng Guo
    Yan-Jiao Yu
    Zhi-Hui Yu
    Hai-Ping Cai
    Wei-Chi Wu
    Jun-Xiao Ma
    Fu-Rong Chen
    Jing Wang
    Zhong-Ping Chen
    Cancer Chemotherapy and Pharmacology, 2020, 86 : 773 - 782
  • [7] Novel focal adhesion kinase 1 inhibitor sensitizes lung cancer cells to radiation in a p53-independent manner
    Jung, Seung-Youn
    Kho, Seongho
    Song, Kyung-Hee
    Ahn, Jiyeon
    Park, In-Chul
    Nam, Ky-Youb
    Hwang, Sang-Gu
    Nam, Seon-Young
    Cho, Seong-Jun
    Song, Jie-Young
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 51 (05) : 1583 - 1589
  • [8] Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide
    Bobustuc, George C.
    Baker, Cheryl H.
    Limaye, Arati
    Jenkins, Wayne D.
    Pearl, Gary
    Avgeropoulos, Nicholas G.
    Konduri, Santhi D.
    NEURO-ONCOLOGY, 2010, 12 (09) : 917 - 927
  • [9] LEVETIRACETAM ENHANCES P53-MEDIATED MGMT INHIBITION AND SENSITIZES GLIOBLASTOMA CELLS TO TEMOZOLOMIDE
    Bobustuc, George C.
    Baker, Cheryl H.
    Limaye, Arati
    Jenkins, Wayne D.
    Avgeropoulos, Nicholas George
    Pearl, Gary
    Konduri, Santhi D.
    NEURO-ONCOLOGY, 2009, 11 (05) : 626 - 626
  • [10] IFN-β Down-Regulates the Expression of DNA Repair Gene MGMT and Sensitizes Resistant Glioma Cells to Temozolomide (vol 65, pg 7573, 2005)
    Natsume, A.
    Ishii, D.
    Wakabayashi, T.
    Tsuno, T.
    Hatano, H.
    Mizuno, M.
    CANCER RESEARCH, 2016, 76 (24) : 7293 - 7293
12345